Mercator Therapeutics Inc. raised $2 million in seed financing from eight unnamed investors, according to documents filed with the SEC, and licensed technology from the University of Texas M.D. Anderson Cancer Center to develop cancer drugs using a first-of-its-kind technology, the company stated. (BioWorld Today) Read More
